SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

BRIEF-Prelude Therapeutics Q3 EPS USD -0.12

Nov 16 (Reuters) - Prelude Therapeutics Q3 net income USD -12.544 million.

PRLD

Related stories